Voices
Giuseppe Caruso: Two Pivotal Studies in Platinum Resistant Recurrent Ovarian Cancer
Giuseppe Caruso/LinkedIn

Giuseppe Caruso: Two Pivotal Studies in Platinum Resistant Recurrent Ovarian Cancer

Giuseppe Caruso, Gynecology Oncology Specialist at European Institute of Oncology, shared a post on LinkedIn:

“April 10, 2026.

Big day in gynonc. Two pivotal studies (KEYNOTE-B96 and ROSELLA) on platinum-resistant recurrent ovarian cancer were published simultaneously in The Lancet Group-both poised to reshape clinical practice.

For a space that has long needed breakthroughs, this feels like a turning point. Let me also say: both first authors are women-something I am genuinely proud of.”

Title: Pembrolizumab plus weekly paclitaxel in platinum-resistant recurrent ovarian cancer (ENGOT-ov65/KEYNOTE-B96): a multicentre, randomised, double-blind, phase 3 study

Authors: Nicoletta Colombo, Emese Zsiros, Gabriella Parma, Eliana Rulli, Alexandra Sebastianelli, Mariusz Bidzinski, Carlos Gallardo, Emad Matanes, Kosei Hasegawa, Fatih Kose, Manuel Magallanes-Maciel, Rebecca A Herbertson, Sumitra Ananda, Judith R Kroep, Andreia Cristina de Melo, Philip R Debruyne, Jae-Weon Kim, Jalid Sehouli, Marc-Edy Pierre, Sakari Hietanen, Claudio Zamagni, Xin Lu, Bradley J Monk, Robert L Coleman, Xuan Peng, Karin Yamada, Agata M Bogusz, Thibault De La Motte Rouge, Xiaohua Wu

Read The Full Article

Giuseppe Caruso

Other articles about Ovarian Cancer on OncoDaily.

Agata M Bogusz Alexandra Sebastianelli Andreia Cristina de Melo Bradley J. Monk cancer Carlos Gallardo Claudio Zamagni Eliana Rulli Emad Matanes Emese Zsiros Fatih Kose Gabriella Parma Giuseppe Caruso Jae-Weon Kim Jalid Sehouli Judith R Kroep Karin Yamada Kosei Hasegawa Manuel Magallanes-Maciel Marc-Edy Pierre Mariusz Bidzinski Nicoletta Colombo OncoDaily Oncology Ovarian Cancer Philip R. Debruyne Rebecca A Herbertson Robert L. Coleman Sakari Hietanen Sumitra Ananda The Lancet Group Thibault de la Motte Rouge Xiaohua Wu Xin Lu Xuan Peng